BioMimetic Therapeutics, Inc. Initiates Enrollment in Augment™ Chronic Tendinopathy Clinical Trial
Jan. 3, 2013
|
|
|
Wright Medical Group, Inc. and BioMimetic Therapeutics, Inc. Enter Into Agreement to Combine Businesses
Nov. 19, 2012
|
|
|
BioMimetic Therapeutics, Inc. Reports Third Quarter 2012 Financial Results
Nov. 5, 2012
|
|
|
BioMimetic Therapeutics, Inc. Reports Second Quarter 2012 Earnings Results
Aug. 2, 2012
|
|
|
BioMimetic Therapeutics, Inc. to Report Second Quarter 2012 Financial Results on August 2
Aug. 1, 2012
|
|
|
BioMimetic Therapeutics Submits Augment® Bone Graft PMA Amendment to FDA
July 9, 2012
|
|
|
Timothy Daniels, MD Presents Results from Augment™ Injectable Bone Graft Clinical Trial
June 25, 2012
|
|
|
Presentations from the Regenerative Strategies and Emerging Technologies Forum at the American Orthopedic Foot and Ankle Society Meeting
June 20, 2012
|
|
|
Presentations from the Regenerative Strategies and Emerging Technologies Forum at the American Orthopedic Foot and Ankle Society Meeting
June 20, 2012
|
|
|
BioMimetic Therapeutics Announces Highlights from 2012 Annual Meeting of Stockholders
June 7, 2012
|
|
|
BioMimetic Therapeutics, Inc. Reports First Quarter 2012 Earnings Results
May 9, 2012
|
|
|
BioMimetic Therapeutics, Inc. to Report First Quarter 2012 Financial Results on May 9
May 7, 2012
|
|
|
BioMimetic Therapeutics, Inc. Reports Fourth Quarter and Year-End 2011 Earnings Results
March 13, 2012
|
|
|
BioMimetic Therapeutics, Inc. to Introduce Augmatrix™ Biocomposite Bone Graft Product Line at AAOS
Feb. 8, 2012
|
|
|
BioMimetic Therapeutics, Inc. to Highlight Product Development Activities at ORS and AAOS Meetings Company Announces Results of its Augment® Rotator Cuff Graft Clinical Trial
Feb. 6, 2012
|
|
|
BioMimetic To Present at 30th Annual J.P. Morgan Healthcare Conference
Jan. 10, 2012
|
|
|
BioMimetic Therapeutics, Inc. to Present at the J.P Morgan Healthcare Conference
Jan. 5, 2012
|
|
|
BioMimetic Therapeutics Receives Augment® Bone Graft PMA Response Letter from FDA
Jan. 3, 2012
|
|
|
BioMimetic Receives PMA Post Panel Response Letter
Jan. 3, 2012
|
|
|
BioMimetic Therapeutics Announces Approval to Market GEM 21S® in the European Union
Jan. 3, 2012
|
|
|
